We came across a bullish thesis on iCAD, Inc. (ICAD) on Twitter by northeasternsvf. In this article, we will summarize the bulls’ thesis on ICAD. iCAD, Inc. (ICAD)'s share was trading at $2.83 as of Feb 20th.
[caption id="attachment_1221543" align="aligncenter" width="768"]iCAD is a leading AI medical technology company focused on innovative cancer detection solutions. Headquartered in Nashua, N.H., the company provides AI-powered mammography analysis through its ProFound Breast Health...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.